{"id":"https://openalex.org/W3029148668","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.e15086","title":"Immunohistochemistry analyses of LAG-3 expression across different tumor types and co-expression with PD-1.","display_name":"Immunohistochemistry analyses of LAG-3 expression across different tumor types and co-expression with PD-1.","publication_year":2020,"publication_date":"2020-05-20","ids":{"openalex":"https://openalex.org/W3029148668","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.e15086","mag":"3029148668"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2020.38.15_suppl.e15086","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.e15086","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.e15086","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025376488","display_name":"Francine Chen","orcid":"https://orcid.org/0000-0001-8459-6304","observed_orcids":["https://orcid.org/0000-0001-8459-6304"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francine Chen","raw_affiliation_strings":["MacroGenics, Inc., Brisbane, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Inc., Brisbane, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Thomas Sherwood","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Sherwood","raw_affiliation_strings":["MacroGenics, Inc., Brisbane, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Inc., Brisbane, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028719199","display_name":"Anushka De Costa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anushka De Costa","raw_affiliation_strings":["MacroGenics, Inc., Brisbane, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Inc., Brisbane, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076399955","display_name":"Nicholas C. Yee-Toy","orcid":"https://orcid.org/0000-0003-1916-6687","observed_orcids":["https://orcid.org/0000-0003-1916-6687"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicholas Yee-Toy","raw_affiliation_strings":["MacroGenics, Inc., Brisbane, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Inc., Brisbane, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045230046","display_name":"Peter Lung","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Lung","raw_affiliation_strings":["MacroGenics, Inc., Brisbane, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Inc., Brisbane, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017159713","display_name":"Ann N. Easton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ann Easton","raw_affiliation_strings":["MacroGenics, Inc., Brisbane, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Inc., Brisbane, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069224914","display_name":"Brad Sumrow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brad Sumrow","raw_affiliation_strings":["MacroGenics, Inc., Rockville, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Inc., Rockville, MD;","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009027578","display_name":"Ezio Bonvini","orcid":"https://orcid.org/0000-0001-9054-3137","observed_orcids":["https://orcid.org/0000-0001-9054-3137"]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ezio Bonvini","raw_affiliation_strings":["MacroGenics, Inc., Rockville, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Inc., Rockville, MD;","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023294934","display_name":"Paul A. Moore","orcid":"https://orcid.org/0000-0001-6057-7539","observed_orcids":["https://orcid.org/0000-0001-6057-7539"]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul A. Moore","raw_affiliation_strings":["MacroGenics, Inc., Rockville, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Inc., Rockville, MD;","institution_ids":["https://openalex.org/I4210106297"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"38","issue":"15_suppl","first_page":"e15086","last_page":"e15086"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lag-3","display_name":"LAG-3","score":0.9929999709129333},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.9959999918937683},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.9150000214576721},{"id":"https://openalex.org/keywords/cervical-cancer","display_name":"cervical cancer","score":0.7089999914169312},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.7720000147819519},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9860000014305115},{"id":"https://openalex.org/keywords/gastric-cancer","display_name":"gastric cancer","score":0.5450000166893005},{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.8069999814033508},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.7360000014305115},{"id":"https://openalex.org/keywords/mesothelioma","display_name":"mesothelioma","score":0.8019999861717224},{"id":"https://openalex.org/keywords/cholangiocarcinoma","display_name":"cholangiocarcinoma","score":0.7480000257492065},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.8920000195503235}],"concepts":[{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.6400690078735352},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.597208559513092},{"id":"https://openalex.org/C2778326572","wikidata":"https://www.wikidata.org/wiki/Q7852668","display_name":"Tumor-infiltrating lymphocytes","level":4,"score":0.5734740495681763},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5521107912063599},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.4629218578338623},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3361080288887024},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23570093512535095},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.23185956478118896}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2020.38.15_suppl.e15086","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.e15086","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.e15086","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4286298878","https://openalex.org/W2911755946","https://openalex.org/W2885310279","https://openalex.org/W4367834424","https://openalex.org/W3027060564","https://openalex.org/W3096533280","https://openalex.org/W3180027691","https://openalex.org/W4386895314","https://openalex.org/W2994950813","https://openalex.org/W2757328282"],"abstract_inverted_index":{"e15086":[0],"Background:":[1],"Concomitant":[2],"blockade":[3],"of":[4,38,52,91,212,282,302,311,326,334,343],"LAG-3":[5,39,59,85,140,172,270,316],"and":[6,15,40,50,64,101,137,197,216,262,279,290,313,329],"PD-1":[7,44,65,312,339],"has":[8],"been":[9],"shown":[10],"to":[11,43,55,191,268,349],"restore":[12],"T-cell":[13],"activation":[14],"enhance":[16],"anti-tumor":[17],"immunity":[18],"in":[19,47,146,186,194,203,277],"preclinical":[20],"models.":[21],"Clinical":[22],"trials":[23],"evaluating":[24],"anti-LAG-3/anti-PD-1":[25],"mAb":[26],"combinations":[27],"or":[28,74,159,336],"bispecific":[29,353],"molecules":[30],"are":[31],"ongoing.":[32],"Establishing":[33],"the":[34,80,210],"tumor":[35,103,208,214,275],"expression":[36,142,173,271,317,345],"profile":[37],"its":[41],"relationship":[42],"will":[45,359],"aid":[46],"patient":[48],"selection":[49],"interpretation":[51],"clinical":[53,347],"responses":[54,348],"combined":[56,75],"inhibition.":[57],"Methods:":[58],"Ab":[60,66],"clone":[61,67],"EPR4392(2)":[62],"(Abcam)":[63],"NAT105":[68],"(Ventana)":[69],"were":[70,222],"developed":[71],"as":[72,154,176,223],"individual":[73],"dual":[76,298],"IHC":[77,86,141,295],"assays":[78],"on":[79,89,274,320],"Ventana":[81],"Discovery":[82],"Ultra":[83],"platform.":[84],"was":[87,143,152,174,189,272,318],"performed":[88],"panels":[90],"commercially":[92],"available":[93],"tissues:":[94],"33":[95],"normal":[96,187,204],"human":[97],"tissues":[98,188],"(2":[99],"each)":[100],"various":[102,207],"types":[104],"including":[105],"anal":[106,228],"(n":[107],"=":[108],"39),":[109],"cervical":[110,225],"cancer":[111,118,126,133],"(40),":[112,116,129],"cholangiocarcinoma":[113,253],"(11),":[114],"DLBCL":[115,231,278],"gastric":[117,240],"(34),":[119],"HCC":[120,250],"(18),":[121],"SCCHN":[122,243],"(39),":[123,131],"HER2-positive":[124,246],"breast":[125,247],"(48),":[127,136],"mesothelioma":[128,263],"NSCLC":[130,234,289,303],"ovarian":[132,256,291],"(47),":[134],"SCLC":[135,259],"TNBC":[138,237],"(40).":[139],"confirmed":[144],"by":[145],"situ":[147],"hybridization":[148],"(ACD":[149],"RNAScope).":[150],"Positivity":[151],"defined":[153,175],"at":[155],"least":[156],"one":[157],"LAG-3+ve":[158,179,213],"PD-1+ve":[160],"tumor-infiltrating":[161],"lymphocyte":[162],"(TIL)":[163],"per":[164,181],"40x":[165],"magnification":[166],"hot":[167],"spot":[168],"field":[169],"(HSF);":[170],"high":[171,217],">":[177],"15":[178],"TILs":[180,321],"HSF.":[182],"Results:":[183],"LAG-3-specific":[184],"staining":[185,201,296],"limited":[190],"mononuclear":[192],"cells":[193,276],"lymphoid":[195],"organs":[196],"GALT,":[198],"with":[199,305,331,338,346],"no":[200],"observed":[202,273],"parenchyma.":[205],"Across":[206],"types,":[209],"frequency":[211],"samples":[215],"expression,":[218],"respectively":[219],"(%,":[220],"%),":[221],"follows:":[224],"(100;":[226],"57.5),":[227],"(97.4;":[229],"30.8),":[230],"(95;":[232],"75),":[233],"(92.3;":[235],"25.6),":[236],"(90;":[238],"22.5),":[239],"(88.2;":[241],"44.1),":[242],"(87.2;":[244],"56.4),":[245],"(85.4;":[248],"39.6),":[249],"(83.3;":[251],"22.2),":[252],"(81.8;":[254],"9.1),":[255],"(70.2;":[257],"21.3),":[258],"(50;":[260],"14.6)":[261],"(25;":[264],"10).":[265],"In":[266],"addition":[267],"TILs,":[269],"a":[280,323],"fraction":[281],"anal,":[283],"breast,":[284],"cervical,":[285],"gastric,":[286],"hepatocellular,":[287],"SCCHN,":[288],"cancers.":[292],"LAG-3/PD-1":[293,344,357],"double":[294],"revealed":[297],"positivity":[299],"across":[300,322],"92.3%":[301],"samples,":[304],"approximately":[306],"60%":[307],"demonstrating":[308],"TIL":[309],"co-expression":[310],"LAG-3.":[314],"Conclusions:":[315],"detected":[319],"broad":[324],"range":[325],"solid":[327],"tumors":[328],"DLBCL,":[330],"varying":[332],"level":[333],"intensity":[335],"association":[337],"expression.":[340],"Correlative":[341],"assessments":[342],"MGD013,":[350],"an":[351],"investigational":[352],"DART(R)":[354],"molecule":[355],"targeting":[356],"(NCT03219268),":[358],"be":[360],"undertaken.":[361]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-06-05T00:00:00"}